Get the Stockscreener App
149.92
2.98%
-4.61
After Hours:
149.92
Krystal Biotech Inc Stock (KRYS) Latest News
Looking Into Krystal Biotech's Recent Short Interest - Benzinga
abrdn plc Boosts Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Lowered by Jennison Associates LLC - MarketBeat
KBC Group NV Purchases 297 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
When the Price of (KRYS) Talks, People Listen - Stock Traders Daily
Krystal Biotech Schedules Critical Year-End Financial Results: Key Details for Biotech Investors - StockTitan
Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 - EIN News
Blue Trust Inc. Acquires 433 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
STATE STREET CORP Reduces Stake in Krystal Biotech Inc - GuruFocus.com
1,400 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Acquired by Pacer Advisors Inc. - Defense World
Krystal Biotech, Inc. (NASDAQ:KRYS) Short Interest Down 8.9% in January - MarketBeat
Janney Montgomery Scott LLC Increases Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Analysts Set Krystal Biotech, Inc. (NASDAQ:KRYS) Target Price at $206.67 - Defense World
Crossmark Global Holdings Inc. Buys 121 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
When (KRYS) Moves Investors should Listen - Stock Traders Daily
Analysts Set Krystal Biotech, Inc. (NASDAQ:KRYS) PT at $206.67 - MarketBeat
Is the Options Market Predicting a Spike in Krystal Biotech (KRYS) Stock? - MSN
US Growth Companies With High Insider Ownership In January 2025 - Simply Wall St
High Growth Tech Stocks to Watch in January 2025 - Simply Wall St
(KRYS)Analyzing Krystal Biotech's Short Interest - Benzinga
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years - Benzinga
Krystal Biotech, Inc. (NASDAQ:KRYS) Short Interest Down 8.9% in December - Defense World
Short Interest in Krystal Biotech, Inc. (NASDAQ:KRYS) Drops By 8.9% - MarketBeat
GAMMA Investing LLC Lowers Stake in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Jeune Aesthetics names new CFO ahead of Phase 2 trials By Investing.com - Investing.com Canada
Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer - GlobeNewswire
Jeune Aesthetics names new CFO ahead of Phase 2 trials - Investing.com
Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer - GlobeNewswire Inc.
Krystal Biotech Becomes Oversold (KRYS) - Nasdaq
JPMorgan Chase & Co. Has $23.28 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
JPMorgan Chase & Co. Has $23.28 Million Stake in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
City Therapeutics Appoints Andy Orth as Chief Executive Officer - Marketscreener.com
Here's How Much $1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today - Benzinga
(KRYS) Proactive Strategies - Stock Traders Daily
Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Krystal Biotech: Blockbuster Ambitions For Topical Gene Therapy (NASDAQ:KRYS) - Seeking Alpha
Principal Financial Group Inc. Sells 3,743 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
(KRYS) Technical Pivots with Risk Controls - Stock Traders Daily
3 US Growth Stocks With Insider Ownership Expecting Up To 85% Earnings Growth - Simply Wall St
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - Yahoo Finance
Avalon GloboCare (NASDAQ:ALBT) vs. Krystal Biotech (NASDAQ:KRYS) Head-To-Head Analysis - Defense World
Krystal Biotech (KRYS) – Research Analysts’ Weekly Ratings Changes - Defense World
Chardan Capital Reaffirms “Buy” Rating for Krystal Biotech (NASDAQ:KRYS) - Defense World
Krystal Biotech reports success with inhalable lung cancer drug in early-stage trial - Mugglehead
KRYS Reports Upbeat Initial Data From Lung Cancer Study Of KB707 - Barchart
KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707 - Yahoo Finance
Geode Capital Management LLC Purchases 11,411 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer - Marketscreener.com
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):